146 related articles for article (PubMed ID: 38570343)
21. The Association between Abdominal Obesity, Metabolic Syndrome and Survival Outcomes in Patients with Breast Cancer.
Taroeno-Hariadi KW; Putra YR; Ariesta NF; Sinorita H; Hardianti MS; Widodo I; Aryandono T
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3157-3165. PubMed ID: 36172679
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
[TBL] [Abstract][Full Text] [Related]
23. Visceral Obesity Is Associated with Shorter Progression-Free Survival in Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Neoplasia.
Santos AP; Rodrigues J; Henrique R; Cardoso MH; Monteiro MP
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294347
[TBL] [Abstract][Full Text] [Related]
24. Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancer.
Anic K; Schmidt MW; Schmidt M; Krajnak S; Löwe A; Linz VC; Schwab R; Weikel W; Brenner W; Westphalen C; Rissel R; Hartmann EK; Conradi R; Hasenburg A; Battista MJ
Front Oncol; 2022; 12():967421. PubMed ID: 36185177
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
[TBL] [Abstract][Full Text] [Related]
26. Risk of type 2 diabetes according to the cumulative exposure to metabolic syndrome or obesity: A nationwide population-based study.
Lee YB; Kim DH; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Han K; Yoo HJ
J Diabetes Investig; 2020 Nov; 11(6):1583-1593. PubMed ID: 32449283
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
[TBL] [Abstract][Full Text] [Related]
28. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
Chambers LM; Jia X; Rose PG; AlHilli M
Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
[TBL] [Abstract][Full Text] [Related]
29. Overall and progression-free survival in endometrial carcinoma: A single-center retrospective study of patients treated between 2000-2018.
Sait KH; Anfinan N; Sait H; Shamrani H; Sait M
Ann Saudi Med; 2023; 43(5):315-328. PubMed ID: 37805818
[TBL] [Abstract][Full Text] [Related]
30. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.
Gonthier C; Walker F; Luton D; Yazbeck C; Madelenat P; Koskas M
Gynecol Oncol; 2014 Apr; 133(1):33-7. PubMed ID: 24680589
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients.
Ding Y; Fan Y; Li X; Wang Y; Wang J; Tian L
Reprod Biol Endocrinol; 2022 Sep; 20(1):134. PubMed ID: 36064542
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Metabolic Syndrome and HDL-C Level Predict the Prognosis of Patients Following Radical Cystectomy: A Propensity Score Matching Study.
Liu Z; Bi H; He W; Zhu X; He J; Lu M; Lu J
Front Oncol; 2022; 12():833305. PubMed ID: 35463353
[TBL] [Abstract][Full Text] [Related]
33. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
34. Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.
Colicchia M; Morlacco A; Rangel LJ; Carlson RE; Dal Moro F; Karnes RJ
Eur Urol Focus; 2019 May; 5(3):425-432. PubMed ID: 29306730
[TBL] [Abstract][Full Text] [Related]
35. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study.
Li Q; Cong R; Wang Y; Kong F; Ma J; Wu Q; Ma X
Gynecol Oncol; 2021 Jan; 160(1):91-98. PubMed ID: 33081984
[TBL] [Abstract][Full Text] [Related]
36. Impact of obesity on surgical and oncologic outcomes in patients with endometrial cancer treated with a robotic approach.
Kawai E; Benoit L; Hotton J; Rance B; Bonsang-Kitzis H; Lécuru F; Balaya V; Ngô C
J Obstet Gynaecol Res; 2021 Jan; 47(1):128-136. PubMed ID: 32820580
[TBL] [Abstract][Full Text] [Related]
37. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation.
Lovic MB; Djordjevic DB; Tasic IS; Nedeljkovic IP
Hellenic J Cardiol; 2018; 59(4):226-231. PubMed ID: 29452307
[TBL] [Abstract][Full Text] [Related]
38. A single centre experience of metabolic syndrome and endometrial carcinoma: 5 years review.
Shafiee MN; Razak N; Ahmad MF; Abd Aziz N; Adeeb N
J Obstet Gynaecol; 2021 Feb; 41(2):285-289. PubMed ID: 33258710
[TBL] [Abstract][Full Text] [Related]
39. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Ding C; Yang Z; Wang S; Sun F; Zhan S
Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
[TBL] [Abstract][Full Text] [Related]
40. Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab.
Bernard L; How JA; Patel S; Yates MS; Jazaeri A
Gynecol Oncol; 2024 Jan; 180():139-145. PubMed ID: 38091773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
